Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

TrumpRx Explained: Why the Drug Discount Site Was 'Never Meant' for Insured Americans as Only 7% Visited It

A senior HHS official says TrumpRx was never meant for insured Americans, as KFF polling shows just 7% of prescription drug users have visited the discount site.

International Business Times UK

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol

The Independent UK

Kalshi to offer betting on drug trial results and FDA regulatory decisions

Move comes as prediction platforms rapidly gain popularity and offer opportunities to bet on virtually anything

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Lancashire chemicals factory facing potential legal claim announces closure

More than 90 residents have expressed interest in contamination claim against AGC Chemicals Europe

The Guardian - UK

AMD FSR Multi-Frame Generation with 8x mode spotted — experimental driver settings could hint at FSR's next evolution

Experimental options discovered in AMD's latest Radeon driver suggest the company is preparing next-generation FSR technologies, but there's no confirmation whether 8x Multi-Frame Generation mode will ever ship in its current form.

Tom’s Hardware

Mapped: New York City’s compromised high-rise leads to closures around major Manhattan landmarks

The 37-story office building had been undergoing extensive renovations to convert it into over 1,600 apartments

The Independent UK

Women Are Getting Hired More After Losing Weight on GLP-1 Drugs: A New Study Raises Difficult Questions

A new study found GLP-1 drug users hired more after weight loss — but researchers say the finding reflects illegal-in-most-states weight discrimination, not just health gains.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Australia To Lose Life-Saving Opioid Drug As Trump Administration Pricing Changes Ripple Worldwide

Australia will lose access to the life-saving opioid treatment Sublocade as experts warn global drug pricing pressures and US policy changes could threaten more medicines.

International Business Times UK

‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year

Exclusive: Fears that US companies may withdraw more medicines as global markets react to policy changes by the Trump administration

The Guardian - AU

Naloxone Access Remains Low Among People Most Likely to Witness an Overdose — Here's How to Get It Right Now

Most Americans who could witness an overdose don't own naloxone. It's OTC at pharmacies. Many states give it free. Here's how to get it, store it, and use it in 2026.

Medical Daily

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy Jr. The agency posted meeting materials online Monday

The Independent UK

Democratic governor slams federal government over DEA fentanyl scandal: ‘They let it in’

New Mexico's governor says the state could seek billions in civil damages after DEA agents allowed fentanyl shipments into communities

The Independent UK

New Mexico opens criminal probe of DEA after agents allowed fentanyl shipments to hit streets

New Mexico's attorney general has opened a criminal investigation into claims that the U.S. Drug Enforcement Administration allowed hundreds of thousands of fentanyl pills to reach the streets

The Independent UK

Medicare Drug Price Negotiation Could Permanently Change What Americans Pay for Prescriptions

CMS proposed making Medicare drug price negotiation permanent on June 12, 2026. Here is what the proposal means for prescription costs, which drugs are covered, and what comes next.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

FDA to discuss easing restrictions on peptides despite safety concerns

Committee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacy

The Guardian - US

Mpox smuggling case prompts congressional scrutiny of National Institutes of Health

House committee seeks records after two agency scientists were charged over undeclared samples

International Business Times

The $70 Billion Shot in the Dark

The global market for drugs like Ozempic, Wegovy, Mounjaro, and Zepbound was worth roughly $70 billion in 2025 and is projected by JP Morgan to exceed $200 billion by 2030.

International Business Times UK

What Is Retatrutide? The Experimental Weight Loss Drug Millions Cannot Access, But Has Sparked a White House Meltdown Over Trump's Health

A 79-year-old man's access to the experimental drug Retatrutide through the FDA's Expanded Access programme has sparked controversy, with allegations of political insider influence and White House denials.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

The $70 Billion Shot in the Dark

The global market for drugs like Ozempic, Wegovy, Mounjaro and Zepbound was worth roughly $70 billion in 2025 and is projected by JP Morgan to exceed $200 billion by 2030.

AAP

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

MELBOURNE, Australia and INDIANAPOLIS, June 23, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces an educational webinar exploring the unmet needs in neurologic oncology (specifically glioma and glioblastoma) and how theranostics may help address these. David N. Cade, MD, Telix Group Chief Medical Officer...

AAP

Biomerics Appoints Kristin Mason as Chief Financial Officer

SALT LAKE CITY, June 22, 2026 /PRNewswire/ -- Biomerics, a leading vertically integrated contract manufacturer for the interventional medical device market, today announced the appointment of Kristin Mason as Chief Financial Officer. Mason joins Biomerics following an extensive career leading finance organizations across complex global businesses. She succeeds the team…

International Business Times UK

US Launches Trade Probe Accusing Germany of Making Medicine 'Too Cheap' As Trump Pushes Global Prices Higher

The US has initiated a Section 301 trade investigation into Germany over low drug prices, potentially leading to tariffs on German pharmaceutical exports.

France 24

US launches Germany pharma pricing probe, raising threat of new tariffs

Germany came under fresh US trade scrutiny on Thursday as the United States launched an investigation into the country's pharmaceutical pricing policies, a move that could pave the way for new tariffs. Washington said it would examine whether Germany's pricing practices unfairly underpay for innovative medicines and burden US commerce…

Medical Daily

Tennessee Became the First State to Let Pharmacies Sell Ivermectin without a Prescription. Here's What That Looks Like Now.

KFF Health News June 17 investigation: Tennessee pharmacies sell ivermectin 10–21x standard potency via one anti-vaccine doctor's blanket prescriptions. 60+ poison center calls in 2025.

Medical Daily

FDA Advisory Panel Votes Today on First mRNA Flu Vaccine as MFLUSIVA Phase 3 Results Face Intense Scrutiny

FDA VRBPAC votes June 18 on Moderna's MFLUSIVA — the first mRNA flu vaccine. Phase 3 showed 26.6% RVE vs. standard dose; 47.9% vs. healthcare outcomes. PDUFA August 5, 2026.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.